Literature DB >> 18514127

Clinical management of thymoma patients.

Erin M Casey1, Patrick J Kiel, Patrick J Loehrer.   

Abstract

Thymoma and thymic carcinomas are rare epithelial tumors that arise from the thymus gland. Current management depends on staging, with surgery being the mainstay of therapy for stages I and II disease. Combined modality therapy, including radiation and chemotherapy, is recommended for patients who have invasive and metastatic disease. Relapse has been documented decades after initial therapy with options for treating recurrent advanced stage disease. Prospective studies have been limited, and current studies aim to evaluate novel treatment options.

Entities:  

Mesh:

Year:  2008        PMID: 18514127     DOI: 10.1016/j.hoc.2008.03.010

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  11 in total

1.  Phase II study of belinostat in patients with recurrent or refractory advanced thymic epithelial tumors.

Authors:  Giuseppe Giaccone; Arun Rajan; Arlene Berman; Ronan J Kelly; Eva Szabo; Ariel Lopez-Chavez; Jane Trepel; Min-Jung Lee; Liang Cao; Igor Espinoza-Delgado; John Spittler; Patrick J Loehrer
Journal:  J Clin Oncol       Date:  2011-04-18       Impact factor: 44.544

2.  FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies.

Authors:  Marcelo F K Benveniste; Cesar A Moran; Osama Mawlawi; Patricia S Fox; Stephen G Swisher; Reginald F Munden; Edith M Marom
Journal:  J Thorac Oncol       Date:  2013-04       Impact factor: 15.609

3.  (18)F-FDG PET/CT is Useful for Pretreatment Assessment of the Histopathologic Type of Thymic Epithelial Tumors.

Authors:  Ji Young Kim; Hye Ok Kim; Jae Seung Kim; Dae Hyuk Moon; Yong Hee Kim; Dong Kwan Kim; Seung-Ii Park; Young Soo Park; Jin-Sook Ryu
Journal:  Nucl Med Mol Imaging       Date:  2010-06-09

Review 4.  The spectrum of ectopic thymomas.

Authors:  Annikka Weissferdt; Cesar A Moran
Journal:  Virchows Arch       Date:  2016-06-02       Impact factor: 4.064

5.  Pretreatment biopsy for histological diagnosis and induction therapy in thymic tumors.

Authors:  Jie Yue; Zhitao Gu; Zhentao Yu; Hongdian Zhang; Zhao Ma; Yuan Liu; Wentao Fang
Journal:  J Thorac Dis       Date:  2016-04       Impact factor: 2.895

6.  Predicting subtypes of thymic epithelial tumors using CT: new perspective based on a comprehensive analysis of 216 patients.

Authors:  Yu-Chuan Hu; Lang Wu; Lin-Feng Yan; Wen Wang; Shu-Mei Wang; Bao-Ying Chen; Gang-Feng Li; Bei Zhang; Guang-Bin Cui
Journal:  Sci Rep       Date:  2014-11-10       Impact factor: 4.379

Review 7.  [Advances on diagnosis and treatment of malignant thymic tumors].

Authors:  Jinghui Wang; Shucai Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-10

8.  Molecular analysis of thymoma.

Authors:  Sunil Badve; Chirayu Goswami; Yesim Gökmen-Polar; Robert P Nelson; John Henley; Nick Miller; Narjis A Zaheer; George W Sledge; Lang Li; Kenneth A Kesler; Patrick J Loehrer
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

Review 9.  [Standard report terms for chest computed tomography reports of anterior mediastinal masses suspicious for thymoma].

Authors:  Edith M Marom; Melissa L Rosado-de-Christenson; John F Bruzzi; Masaki Hara; Joshua R Sonett; Loren Ketai
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2014-02

10.  [Pretreatment Biopsy for Histological Diagnosis and Induction Therapy in Thymic Tumors].

Authors:  Jie Yue; Zhitao Gu; Zhentao Yu; Hongdian Zhang; Zhao Ma; Yuan Liu; Wentao Fang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.